MedBridge NZ

Home > Blog > Advanced Therapies & Technology Key Takeaways China currently hosts over 700 active CAR-T clinical trials, leading global research in dual-target therapies and solid tumor applications. Advanced manufacturing platforms in China can compress the cell preparation cycle to 24-36 hours, significantly reducing patient wait times compared to the standard 2-4 weeks in Western systems. Commercial CAR-T therapy in China generally ranges from $120,000 to $220,000, presenting a...

Home > Blog > Travel & Hospital Navigation Key Takeaways Visa-Free Corridors: Patients from select countries can utilize the Hainan 30-day visa-free policy or the 240-hour transit visa for immediate, short-term diagnostic or specialized pharmacological needs. S2 Medical Visa Prerequisites: Long-term treatments (up to 180 days) require an S2 visa, which mandates a formal invitation letter bearing an official "Red Seal" from a recognized Top-Tier (Grade 3A) public hospital. Systemic...

Home > Blog > Advanced Therapies & Technology Key Takeaways High-Volume Clinical Experience: Top-tier hospitals in China, such as the Children's Hospital of Fudan University, process a significant volume of rare disease cases, providing multidisciplinary teams (MDTs) with extensive data and practical expertise. Advanced Base-Editing Technology: Chinese researchers are utilizing transformer Base Editor (tBE) technology in clinical trials, which aims to modify specific bases without causing...